These findings, in conjunction with the observed enhancement of HER-2(15776)-specific T cell proliferation, suggest that in the presence of tumor antigenic peptides, proTα- and proTα(100–109)-matured DCs efficiently promote the expansion of peptide-specific T cells. The gene discussed is ERBB2; the disease is neoplasm.